Introduction
============

Hepatitis B virus (HBV) infection is a major global health problem \[[@B1]-[@B3]\], especially in Asia, Africa, southern Europe and Latin America \[[@B4]\]. About 2 billion people are infected with HBV worldwide \[[@B2],[@B4],[@B5]\], and 400 million among them are suffering from chronic HBV infection \[[@B6]\]. Pakistan is highly endemic with HBV \[[@B7]\] with nine million people infected with HBV \[[@B8]\] and its infection rate is on a steady rise \[[@B9]\]. The reason may be the lack of proper health facilities, poor economical status and less public awareness about the transmission of major communicable diseases including HBV, HCV and HIV \[[@B6]\].

The clinical course and sequel of chronic hepatitis vary among individuals. Infection with HBV leads to a wide spectrum of clinical presentations, ranging from asymptomatic carrier state to acute self-limiting infection or fulminant hepatic failure, chronic hepatitis with progression to cirrhosis, and hepatocellular carcinoma (HCC) \[[@B2]\].

Studies are too limited to give a clear picture of the prevalence of HBV at the National level, especially among otherwise healthy individuals. Most previous studies targeted different small groups of individuals with some clinical indications therefore; these do not accurately reflect the overall prevalence in Pakistan \[[@B7],[@B8]\]. The present article briefly presents the prevalence, risk factors associated with HBV transmission, awareness status and HBV genotypes prevalent in Pakistani population.

Literature Search and inclusion criteria
========================================

Articles were searched in PubMed, PakMediNet, Directory of Open Access Journals (DOAJ) and Google Scholar by using keywords; Hepatitis B virus in Pakistan, Prevalence of HBV in Pakistan, HBV in Blood donors, Hepatitis B virus in general population, HBV in Pakistani healthcare workers, HBV in surgical patients, HBV infection in women and children, HBV infection in prisoners, HBV in diseased population in Pakistan, HBV in injection drug users, epidemiology of HBV in Pakistan, HBV genotypes in Pakistan and awareness about HBV in Pakistani population. Two hundreds and twenty nine different studies (articles/repots) were obtained from the literature search, out of which 106 published from 1998 to 2010 were included in the present review. Studies full filling the following criteria were included: 1) Samples were collected from Pakistani individuals. 2) An obvious description of the methods of detection of HBV infection and genotyping. 3) Information about the number of individuals studied and their residing area were reported. 4) Studies reporting risk factors and awareness status in Pakistani population were included to discuss the HBV prevalence in different population groups.

Analysis
========

Studies showing percent prevalence of HBV infection in different population are shown in table [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, while table [5](#T5){ref-type="table"} shows the percentage of different genotypes prevalent in Pakistan. The percent prevalence in the different population groups are presented in mean ± standard deviation (with 95% confidence interval).

###### 

Prevalence of HBV in general population, young recruits and prisoners.

  Population type          Region                            Methods                         Population size   HBV (%)   HBV marker                  Reference
  ------------------------ --------------------------------- ------------------------------- ----------------- --------- --------------------------- ----------------------------------
  **General population**   Lahore                            ELISA                           992               8.06%     HBsAg                       Nafees *et al*. \[[@B10]\] 2009
                           Larkana                           ICT, ELISA                      200               4.8%      HBsAg                       Shaikh *et al*. \[[@B11]\] 2009
                           Lahore                            ICT                             203               2.46      HBsAg                       Tanveer *et al*. \[[@B12]\] 2008
                           Karachi                           ICT, ELISA.                     4000              4.5%      HBsAg                       Noorali *et al*. \[[@B7]\] 2008
                           Southern Punjab                   ICT/ELISA                       1821              5.9%      HBsAg                       Mirza *et al*. \[[@B13]\] 2007
                           Karachi                           ICT, ELISA and PCR.             3820              4.5%      HBsAg & DNA                 Hakim *et al*. \[[@B8]\] 2008
                           Islamabad                         AxSym HBsAg, CORE& AUSAB MEIA   1300              4%        HBsAg, anti HBs, anti HBc   Alam *et al*. \[[@B6]\] 2007
                           Central Punjab                    ICT, ELISA                      2038              4.83%     HBsAg                       Alam *et al*. \[[@B14]\] 2006
                           Rawalpindi                        ELISA                           665               3%        HBsAg                       Farooq *et al*. \[[@B15]\] 2005
                           Lahore                            ICT                             757               2.6%      HBsAg                       Amin *et al*. \[[@B16]\] 2004
                           Karachi                           ICT, ELISA                      200               3%        HBsAg                       Qasmi *et al*. \[[@B17]\] 2000
  **Recruitments**         Rural Areas of Pakistan           ICT, ELISA                      3320              4.5%      HBsAg                       Azam *et al*. \[[@B18]\] 2009
                           Interior Sindh                    ICT, ELISA                      5237              7.39%     HBsAg                       Malik *et al*. \[[@B19]\] 2008
                           Recruits from all over Pakistan   ICT, ELISA                      2558              2.8%      HBsAg                       Sherif & Tariq, \[[@B20]\] 2006
                           Mardan                            ICT, ELISA                      15550             3.24%     HBsAg                       Mirza *et al*. \[[@B21]\] 2006
                           All areas of Pakistan             ICT, ELISA                      4552              4.2%      HBsAg                       Hussain *et al*. \[[@B22]\]2005
                           All areas of Pakistan             ICT, ELISA                      5371              3.53%     HBsAg                       Ali *et al*. \[[@B23]\] 2002
  **Prisoners**            Karachi                           ELISA                           365               5.9%      HBs Ag                      Kazi *et al*. \[[@B24]\] 2010
                           Bahawalpur                        ICT, ELISA                      2086              5.6%      HBs Ag                      Fayyaz *et al*.\[[@B25]\] 2006

ELISA: Enzume linked immunosorbant assay; HBsAg: hepatitis B surface antigen; ICT: Immuno-chromatographic Test, MEIA: Microparticle Enzyme Immunoassay, HBsAg: hepatitis B surface antigen

###### 

Percent prevalence rates of HBV in Healthy Blood donors.

  -------------------------------------------------------------------------------------------------------------------------------------------------
  Population type            Region              Methods      Population size   HBV positive (%)   HBV marker   Reference
  -------------------------- ------------------- ------------ ----------------- ------------------ ------------ -----------------------------------
  **Healthy Blood Donors**   Kurram Agency       ICT          1300              5.07%              HBsAg        Bangash *et al*. \[[@B26]\] 2009

                             Interior\           ICT          5345              6.2%               HBsAg        Mujeeb & Pearce, \[[@B27]\] 2008
                             Sindh                                                                              

                             Karachi             ICT          11459             1.71%              HBsAg        Nazar *et al*. \[[@B28]\] 2008

                             Karachi             ICT          688               4.50%              HBsAg        Azam *et al*. \[[@B29]\] 2007

                             Northern areas      ICT          8949              3.66%              HBsAg        Alam & Naeem, \[[@B30]\] 2007

                             Karachi             ICT          21,125            3.3%               HBsAg        Mujeeb & Pearce, \[[@B31]\] 2007

                             District Thatta     ICT          310               5.81%              HBsAg        Ishaq *et al*. \[[@B32]\] 2007

                             Southern Punjab     ICT, ELISA   27938             2.69%              HBsAg        Khan *et al*. \[[@B33]\] 2006

                             Lahore              ICT          18216             3.36%              HBsAg        Sirhindi *et al*. \[[@B34]\] 2005

                             Karachi             ELISA        351309            2.0%               HBsAg        Akhtar *et al*. \[[@B35]\] 2005

                             Peshawar/\          MEIA         4000              1.9%               HBsAg        Ahmad *et al*. \[[@B36]\] 2004
                             KPK                                                                                

                             Rawalpindi          ICT          580               5.86%              HBsAg        Mumtaz *et al*. \[[@B37]\] 2002

                             Northern Pakistan   ELISA        103858            3.3%               HBsAg        Khattak *et al*. \[[@B38]\] 2002

                             Bahawalpur          LAT, ICT     345               5.64%              HBsAg        Fayyaz *et al*. \[[@B39]\] 2002
  -------------------------------------------------------------------------------------------------------------------------------------------------

LAT: Latex agglutination test

###### 

Percent prevalence rates of HBV infection in Healthcare workers, pregnant women and pediatric population.

  Population type             Region           Methods       Population size   HBV positive (%)   HBV marker                    Reference
  --------------------------- ---------------- ------------- ----------------- ------------------ ----------------------------- -----------------------------------
  **Health Care Personals**   Abbottabad       ELISA         125               2.4%               HBsAg                         Sarwar *et al*. \[[@B41]\] 2008
                              Muzaffarabad     RPHA, ELISA   199               4.1%               HBsAg                         Naz *et al*. \[[@B42]\] 2002
  **Pregnant women**          Karachi          ICT           2592              0.34%              HBsAg                         Sheikh, \[[@B43]\] 2009
                              Swat             ICT, ELISA    5607              3.98%              HBsAg                         Khattak *et al*. \[[@B44]\] 2009
                              Karachi          EIA           5902              4.6%               HBsAg                         Sami *et al*. \[[@B45]\] 2009
                              Lahore           ICT, ELISA    2439              2.2%               HBsAg                         Batool *et al*. \[[@B46]\] 2008
                              Bahawalpur       ICT, ELISA    300               12.3%              HBsAG, HBeAG, HBcAB, HBsAB,   Ahmad *et al*. \[[@B47]\] 2007
                              Karachi          ICT, ELISA    25,482            1.57%              HBs Ag                        Ali & Memon, \[[@B48]\] 2007
                              Hyderabad        ICT, ELISA    103               12.6%              HBsAg                         Yousfani *et al*. \[[@B49]\] 2006
                              Rahim Yar Khan   ELISA         450               12.0%              HBsAg                         Hakeem *et al*. \[[@B50]\] 2006
                              Karachi          ICT, ELISA    245               3.26%              HBsAg                         Mehnaz *et al*. \[[@B51]\] 2002
  **Children**                Karachi          ELISA         3533              1.8%               HBsAg                         Jafri *et al*. \[[@B52]\] 2006
                              Lahore           RPHA, ELISA   392               2.04%.             HBsAg                         Khan *et al*. \[[@B53]\] 1998

EIA: Enzyme Immunoassay, RPHA: Reverse Passive Hemagglutination Technique

###### 

Percent prevalence of HBV infection in patients of different diseases in Pakistan.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Population type                                    Region               Methods               Population size   HBV positive(%)   HBV marker                                Reference
  -------------------------------------------------- -------------------- --------------------- ----------------- ----------------- ----------------------------------------- ------------------------------------
  **Surgical patients**                              Karachi              EIA                   496               5.0%              HBsAg                                     Moosa *et al*. \[[@B57]\] 2009

                                                     Jacobabad Sindh      ICT                   150               9.33%             HBsAg                                     Daudpota & Soomro, \[[@B58]\] 2008

                                                     Karachi              ELISA                 387               6.5%              HBsAg                                     Masood *et al*. \[[@B59]\] 2005

                                                     Karachi              Latex method, ELISA   411               8.76%             HBsAg                                     Shirazi *et al*. \[[@B60]\] 2004

  **Patients with cirrhosis**                        Saidu Sharif, Swat   ELISA                 110               21.81%            HBsAg                                     Khan *et al*. \[[@B62]\] 2009

                                                     Dera Ismail Khan     ICT                   60                46.67%            HBsAg                                     Mashud *et al*. \[[@B63]\] 2004

                                                     Lahore               ICT, ELISA            94                23%               HBsAg, anti-HBcIgG, anti-HBs, and HBeAg   Khan *et al*. \[[@B64]\] 2002

                                                     Lahore               ELISA                 50                24%               HBsAg                                     Hussain *et al*. \[[@B65]\] 1998

  **Patients with Hepatocellular carcinoma (HCC)**   Hyderabad            ELISA                 200               21.0%             HBsAg                                     Ansari *et al*. \[[@B66]\] 2009

                                                     Rawalpindi           ICT, ELISA            44                25%               anti-HBsAg, anti-HBcAb antiHBeAb          Mumtaz *et al*. \[[@B67]\] 2001

                                                     Lahore               ELISA                 30                20%               HBsAg                                     Kausar *et al*. \[[@B68]\] 1998

  **Patients with hepatitis**                        Rawalpindi           ICT                   264               9.8%              HBsAg                                     Mumtaz & Aftab \[[@B69]\] 2005

                                                     Hyderabad/Jamshoro   ELISA                 100               41%               anti-HBs\                                 Almani *et al*. \[[@B70]\] 2002
                                                                                                                                    anti-HBc                                  

                                                     Islamabad            ELISA                 2574              15%               HBsAg                                     Tanwani & Ahmad \[[@B71]\] 2000

                                                     Karachi              MEIA-Abbott           1225              2%                HBsAg                                     Mahmood \[[@B72]\] 2000

                                                     Rawalpindi           RPHA or ELISA         4315              11.68%            HBsAg                                     Hussain &\
                                                                                                                                                                              Ahmed \[[@B73]\] 1998

  **Patients of Liver disease**                      Karachi              ICT, ELISA, PCR       5193              32.6%             HBsAg                                     Ahmed *et al*. \[[@B74]\] 2010

                                                     Peshawar             ICT, ELISA and PCR.   181               18.23%            HBs Ag or DNA                             Khan \[[@B75]\] 2006

                                                     Faisalabad           ELISA                 100               29%               HBsAg                                     Bilal *et al*. \[[@B76]\] 2006

                                                     Hazara Division      ICT                   893               30.35%            HBsAg                                     Khan and Rizvi \[[@B77]\] 2003

  **MTP (Thalassemic & Hemophiliac Children)**       Islamabad            ICT, ELISA            251               3.9%              HBsAg                                     Burki *et al*. \[[@B79]\] 2009

                                                     Peshawar             ELISA                 250               8.4%              HBsAg                                     Shah *et al*. \[[@B80]\] 2005

                                                     Peshawar             ELISA                 80                7.591             HBsAg                                     Mohammad *et al*. \[[@B81]\] 2003

                                                     Peshawar             ELISA                 40                5%                HBsAg                                     Hussain *et al*. \[[@B82]\] 2003

  **Ophthalmic Patients**                            Jamshoro/Hyderabad   ICT                   931               4.6%              HBsAg                                     Junejo *et al*. \[[@B88]\] 2009

                                                     Dera Ismail Khan     ICT, ELISA            1130              3.18%             HBsAg                                     Ahmad *et al*. \[[@B89]\] 2006

  **IDU**                                            Peshawar             ELISA                 250               22.4%             HBsAg                                     Alam *et al*. \[[@B86]\] 2007b

                                                     Karachi              ELISA                 161               7.5%              HBsAg                                     Altaf *et al*. \[[@B87]\] 2007
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MTP: Multi-transfused Population, IDU: Injecting drug Users

###### 

Summaries of the studies conducted on prevalence of HBV genotypes in Pakistan.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                                 Region                             Patients (n)   Genotype A     Genotype B     Genotype C    Genotype D      Genotype E   Genotype F   Untypable     Mixed
  --------------------------------------- ---------------------------------- -------------- -------------- -------------- ------------- --------------- ------------ ------------ ------------- --------------
  **Awan *et al*.**\[[@B96]\]**2010**     All areas of Pakistan              300            43 (14.33%)    54 (18%)       83 (27.66%)   39 (13%)        2 (0.66%)    4 (1.33%)    31 (10.33%)   44 (14.66%)

  **Ahmed *et al*.**\[[@B97]\]**2009**    Punjab and Sindh                   236            2 (0.85%)      \-             14\           220 (93.22%)    \-           \-           \-            \-
                                                                                                                          (5.93%)                                                               

  **Baig *et al*.**\[[@B98]\]**2009**     Karachi                            315            65 (20%)       \-             \-            219 (70%)       \-           \-           \-            31 (10%)

  **Noorali *et al*.**\[[@B7]\]**2008**   Karachi                            180            \-             \-             \-            150 (83.33%)    \-           \-           \-            30 (16.66%)

  **Hakim *et al*.**\[[@B8]\]**2008**     Karachi                            180            \-             \-             \-            151 (83.89%)    \-           \-           \-            29 (16.11%)

  **\*Alam *et al*.**\[[@B99]\]**2007**   Patients from All four Provinces   110            5 (4.55)       27(24.54%)     \-            66 (60%)        \-           \-           9 (8.18%)     3 (2.73%)

  **Baig *et al*.**\[[@B100]\]**2007**    Karachi                            295            60 (20.34%)    \-             \-            208 (70.51%)    \-           \-           \-            27 (9.15%)

  **Alam *et al*.**\[[@B86]\]**2007**     KPK                                56             15 (8.92%)     \-             \-            35 (62.5%)      \-           \-           \-            16 (28.57%)

  **Abbas *et al*.**\[[@B101]\]**2006**   Karachi                            109            \-             \-             \-            109 (100%)      \-           \-           \-            \-

  **Idrees *et al*.**\[[@B1]\]**2004**    Patients from All four Provinces   112            24 (21.42%)    20 (17.86%)    46 (41.07%)   9 (8.03%)       \-           \-           5 (4.46%)     8 (7.14%)

  **Total**                                                                  1893           190 (10.03%)   101 (5.335%)   143 (7.55%)   1206 (63.71%)   2 (0.105%)   4 (0.21%)    45 (2.377%)   188 (9.931%)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

KPK: Khyber Pakhtunkhwa Province

\*The percentage values are different in the original manuscript as the authors considered the untypable samples as negative for genotype.

Formula used for determination of mean prevalence in each population group

$$\mu = (\Sigma\text{~x}_{\text{i}})/\text{N}$$

Formula used for determination of standard deviation (SD) in each population group

$$\sigma = \sqrt{\frac{1}{N}{\sum\limits_{i = 1}^{N}\left( {x_{i} - \mu} \right)^{2}}}.$$

Where \"x\" is the percent HBV prevalence reported in each study and \"N\" is the total number of studies in the population groups.

HBV prevalence in various population groups
===========================================

General population (healthy population)
---------------------------------------

Eleven different studies reported the percent prevalence rates of hepatitis B virus of in general population as 4.3318% ± 1.644% (2.46%-8.06%) \[[@B6]-[@B8],[@B10]-[@B17]\], while six different studies involving healthy recruits showed the prevalence rate of 4.276% ± 1.646%. \[[@B18]-[@B23]\]. HBV prevalence of 5.75% ± 0.212% was observed in prisoners \[[@B24],[@B25]\]. Fourteen different studies showed the prevalence rate of 3.93% ± 1.58% in healthy blood donors in Pakistan \[[@B26]-[@B39]\]. HBV prevalence of 9.0% has been reported in professional blood donors \[[@B40]\]. Two different studies showed the prevalence of HBV in health care workers as 3.25% ± 1.202% \[[@B41],[@B42]\]. Nine studies showed the HBV prevalence of 5.872% ± 4.984% in pregnant women \[[@B43]-[@B51]\], while two different studies demonstrated 1.92% ± 0.169% prevalence in children \[[@B52],[@B53]\]. A very high frequency of ≥12% HBV infection in pregnant females has been reported in Bahawalpur, Hyderabad and Rahim Yar Khan regions \[[@B47],[@B49],[@B50]\]. Up to 21% of the children born of HBV infected females were infected \[[@B47]\], while Kazmi *et al*. \[[@B54]\] showed a high prevalence of 90% in children born of HBV positive mothers. Quddus *et al*. \[[@B55]\] showed HBV prevalence of 8.3% in Afghan refuges residing in Pakistan. Anwar *et al*. \[[@B56]\] showed a high prevalence rate of HBV that was 11.65% in female prostitutes in Lahore, Pakistan. Frequency of viral hepatitis in blood donors is higher in Bahawalpur as compared to rest of the world \[[@B33]\].

These studies show that Southern Punjab, Interior Sindh, District Tatta, Kurrum agency and some areas of Lahore have very high HBV prevalence of \>5%, hence mass vaccination and awareness programs in these areas on urgent basis is suggested.

Surgical patients
-----------------

Four different studies showed 7.397% ± 2.012% HBV prevalence rates in patients undergoing surgery \[[@B57]-[@B60]\]. The lack of routine serological screening in Pakistani hospitals prior to surgery is one of the factors responsible for increased disease transmission \[[@B59]\]. It is recommended that every case undergoing surgery should be screened for hepatitis B and C virus infections \[[@B61]\].

Patients with hepatitis, liver diseases, HCC and cirrhosis
----------------------------------------------------------

Four different studies showed the percent HBV prevalence of 28.87% ± 11.90% in patients with cirrhosis \[[@B62]-[@B65]\] while 22% ± 2.645% HBV prevalence was shown by three different studies in patients with HCC \[[@B66]-[@B68]\]. Five studies in patients with hepatitis showed the percent prevalence of 15.896% ± 14.824% \[[@B69]-[@B73]\] while four different studies in patients with different liver diseases showed the prevalence of HBV as 27.54% ± 6.385% \[[@B74]-[@B77]\].

Muti-tranfused population (thalassemic and hemophilic patients)
---------------------------------------------------------------

Thalassemic and hemophilic patients require life-long blood transfusions, so it is necessary to obtain screened blood from a reputable source, because the multitransfused population is more prone to blood-borne pathogens \[[@B78]\]. Four different reports showed percent HBV infection of 6.223% ± 2.121% in multi-tranfused population \[[@B79]-[@B82]\].

Intravenous drug users (IDU)
----------------------------

Pakistan is estimated to have 4 to 4.8 million drug users with 180,000 IDUs \[[@B83]\]. Strathdee *et al*. \[[@B84]\] observed significant increase in needle sharing in IDUs since 2001. Among them Afghan refugees have higher levels of needle sharing as compared to the local IDUs \[[@B85]\]. Two different reports showed a very high HBV prevalence of 14.95% ± 10.536% in injection drug users \[[@B86],[@B87]\].

Patients with other diseases
----------------------------

Two different reports show the prevalence of HBV in ophthalmic patients to be 3.89% ± 1.004% \[[@B88],[@B89]\], percent prevalence of HBV was 12.4% in patients on hemodialysis \[[@B90]\], 26% in psychiatric patients \[[@B91]\], 10.2% in patients advised for liver function tests \[[@B92]\], 1.5% in patients with dermatoses caused by *lichen planus*\[[@B93]\] and 2.02% in orthopedics patients \[[@B94]\]. High prevalence among psychiatric patients could be due to razor sharing, facial and armpit shaving from barbers and carelessness during injuries.

Genotypes
---------

Hepatitis B virus exists in eight different genotypes (A-H) and its prevalence differs with differs by geography and ethnicity \[[@B95]\]. Ten different studies (Table [5](#T5){ref-type="table"}) conducted at different regions of Pakistan showed that the most prevalent HBV genotype in Pakistan is genotype D with overall prevalence rate of 63.71% followed by genotype A (10.036%), genotype C (7.55%) and genotype B (5.335%) while untypable and mixed genotypes were 2.377% and 9.931%, respectively \[[@B1],[@B7],[@B8],[@B87],[@B97]-[@B102]\]. The most detailed study recently conducted by Awan *et al*. \[[@B96]\] showed that the most emerging genotype in Pakistani population is genotype C with the prevalence rate of 27.66%, which is a bad news as it is more common in cirrhotic patients and is known to be associated with more severe liver diseases. Moreover, Previous studies also shows that genotype D have more severe disease, less responsive to interferon therapy as compared to genotype A and B and have higher HBV DNA levels. This genotype also has specific viral sequence patterns that may predict long-term response to lamivudine treatment \[[@B101]\]. However, further studies are needed to characterize prevalence of different genotypes, their relative severity and treatment response rates in Pakistani population.

Risk factors associated with HBV infection
------------------------------------------

History of dialysis for more than 2 years is a risk factor for dialysis patients \[[@B90]\]. Major risk factors for mother to infant transmission include increasing maternal age, number of pregnancies, repeated injections and addiction \[[@B51]\]; major risk factors in surgical patients include re-use of contaminated syringes, contaminated surgical instruments and blood products \[[@B59]\]; risk factors in pregnant women (antenatal) include ear and nose prick, history of jaundice among them or with their partner \[[@B49]\], history of blood transfusions, history of injections \[[@B46],[@B49]\], tooth extraction \[[@B46]\]; in prisoners significant risk factors were intravenous drug abuse \[[@B24],[@B25]\], rural origin and shaved by barber \[[@B25]\]; in orthopedic patients common risk factors are previous history of surgery or blood transfusion \[[@B94]\]. Major risk factors for health care workers are dental procedures, needle prick and surgical procedures \[[@B41]\]; most important risk factors for HBV infection in young *recruits*were sharing of razors, history of intravenous injections, jaundice in the subject and jaundice in family \[[@B22]\]; in children key risk factors were injection in the past, surgical and dental procedures, blood transfusion, accidental cuts at barber shops and umbilical cord cut through unsterilized instruments at home \[[@B102]\]; in thalassaemic children there is a definite risk factor of repeated blood transfusion \[[@B79]\], while main risk factors among the obstetrical and gynecological population were unsafe surgery, injections and inadequately screened blood transfusions \[[@B45]\]. Qureshi *et al*. \[[@B103]\] compared male patients suffering from chronic hepatitis with healthy people as control and found very strong relationship of the HBV infection with history of dental treatment, surgery and history of taking injections. It is established fact that HBsAg does not cross the placental barrier however; the infection in children/newborns may occur at the time of birth or soon after birth. The infants of HBV positive mothers must be vaccinated soon after birth and HBIG immediately within 24 hours of birth \[[@B54]\]. Relatively low prevalence in the female prostitutes (high risk group) reflects the effect of legal, social and religious constraints in Pakistani society \[[@B56]\]. Many of the Afghan refuges (most of them are children) are rag pickers who collect used syringes and needles dumped outside the hospitals and hence are one of the most vulnerable groups to viral hepatitis in Pakistan \[[@B104]\]. Most of these factors are easily preventable and need awareness in general population and the healthcare workers.

Preventive strategies for HBV infection include healthy blood transfusion services along with safe sex \[[@B34]\], vaccination against HBV \[[@B40],[@B103]\], shaving by barbers needs to be discouraged \[[@B103]\] and better training of healthcare workers \[[@B105]\]. Paid blood donation should be prohibited \[[@B85]\]. All patients needing surgery should be screened for viral hepatitis and there should be separate operation theatres facilities for these patients \[[@B94]\]. In addition reuse of razors in many barber shops that may spread hepatitis in a substantial number of individuals \[[@B106]\] and must be discouraged. Importantly, the most common risk factors and modes of HBV transmission in this country differ in importance in various community groups \[[@B23]\].

In Turkish population, HLA-A24 and Cw1 has been associated with low risk for HBV-related chronic liver disease and HLA- B13, B8, DR7, DR13 and DQ3 were found associated with high risk for chronic HBV infection \[[@B107]\]. However, there is no study that describes cellular or molecular mechanism of HBV infection in Pakistani population.

Awareness about HBV in Pakistani population
-------------------------------------------

Nasim *et al*. \[[@B108]\] conducted a questioner bases survey in Karachi to assess knowledge about viral hepatitis among college girls and showed that 57% of them do not have information about transmission of hepatitis B virus. In another survey \[[@B109]\] at obstetric and gynecology clinic at Hyderabad showed that most of the women (67.76%) know that HBV is a viral disease, 75.20% responded that it affect liver, 33.88% believed that it could be transmitted by infected blood transfusion, 17.35% believed that it could be transmitted from mother to child, 19.0% mentioned sexual intercourse responsible for HBV infection, while 40.49% and 38.0% mentioned contaminated needles and un-sterilised instruments as a source of HBV infection, respectively. Mengal *et al*. \[[@B110]\] surveyed nursing students at nursing school, Bolan medical complex hospital, Quetta and reported that only 37.2% of them were completely vaccinated and 25.0% had not been vaccinated for HBV. Chaudhry *et al*. \[[@B111]\] repoted that 97.4% of the barbers at Islamabad use new blade for every customer but only 38% of them has knowledge about routes of infection of HBV and HCV. In another study, Waheed *et al*. \[[@B112]\] reported that 39.6% of the barbers at Rawalpindi and Islamabad knew that Hepatitis B and hepatitis C were viral diseases, 90.7% thought that hepatitis could spread by blade sharing, 26.6% knew that it can lead to cancer and 47.8% knew that a vaccine for HBV was available. Ali *et al*. \[[@B113]\] reported that 78.8% of the rural population of Faisalabad was unaware of viral hepatitis. In another study, Asif *et al*. \[[@B114]\] reported that only 17.6% of the rural population of Nowshera was aware of the fact that Hepatitis B and C are transmitted by a virus. Talpur *et al*. \[[@B115]\] stated that there is significant lack of knowledge and poor attitude towards HBV and HCV in surgical patients at Nawabshah area. We suggest aggressive public awareness programs especially in rural areas and people at high risk to decrease the burden of HBV infection in Pakistan.

Conclusions
===========

This article reviews prevalence of HBV in different areas and population groups in Pakistan, along with awareness status, risk factors and genotypes in Pakistani population. Prevalence of HBV infection varies with population residing in different regions of Pakistan. The present literature shows that Afghan refuges in Pakistan, IDUs, professional blood donors, health care professionals, prisoners, multiple transfused patients, patients with HCC, psychiatric patients, general population of some specific areas like Southern Punjab, Interior Sindh, District Tatta, Kurrum agency, Baltistan and some areas of Lahore have very high HBV prevalence of more than 5%, and there is urgent need of mass vaccination and awareness programs. Further studies are needed to characterize HBV prevalent in Pakistan at molecular level. Moreover, both host and viral factors associated with molecular and cellular mechanism of HBV infection in Pakistani population needs to be explored.
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